From gummies to pet care – these are some of the most popular CBD products purchased during the pandemic.
It has been widely reported that sales of CBD products have shot up since the outbreak of Covid-19, as people become more aware of their health and wellbeing.
Now a new case study published by JustCBD has revealed some of the most popular CBD products in the UK and USA throughout the pandemic.
The case study was conducted by performing a statistical analysis of the company’s sales data over the last year.
Gummies were among the most popular choices throughout the UK, with particular hotspots including Aberdeen, Belfast, Canterbury, Durham, Leeds, Liverpool, Sheffield and York.
While vegan options were commonly purchased in Bangor, Cambridge, Glasgow, Nottingham and Peterborough.
Full-spectrum oil is also a favourite both in the UK and the USA, frequently bought by those in Coventry and Dundee.
However, consumers in Gloucester, Cardiff, Exeter and Londonderry preferred CBD isolate.
Capsules were a common consumption method in Manchester, in Stoke-on-Trent it was vape pens, and in Birmingham and Oxford residents preferred a soak with a CBD bath bomb.
During the pandemic taking care of our four-legged friends also appears to have become more important in the UK.
The case study shows that people in Hereford, Kingston upon Hull, Lancaster and London have bought oils for their cats and dogs.
Although there is not enough evidence for vets to recommend CBD oil yet, pet owners often report that the supplement has helped their cat or dog, especially in the case of anxiety and joint disorders.
As previous reports have revealed, one of the biggest reasons for using CBD products is pain management.
The case study shows that pain cream has been the top product for consumers in Bath and Norwich.
Nataly Komova, a certified nutritionist working for JustCBD, commented: “People are looking for different ways of consuming CBD oil. What the case study shows – edibles have become popular, as they are very accessible for virtually everyone and can be consumed on the go without any stigma attached to CBD products.”
- The role of the endocannabinoid system in dermatological diseases
- Cannabis may help reduce reliance on other stimulants, finds study
- Greece welcomes ‘new era’ of medical cannabis after seven-year wait
- Spain publishes draft medical cannabis framework, but omits flower
- Broughton: How to design a robust CBD testing strategy
- Medical Cannabis Division of Rokshaw Ltd Rebranding to Curaleaf Laboratories
News5 months ago
FSA drops recommended daily dose of CBD to 10mg – everything you need to know
Pain6 months ago
Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study
News4 months ago
UK government accepts ACMD recommendations for CBD products
Industry5 months ago
First UK-grown cannabis medicine expected by end of 2023
News6 months ago
The Netherlands to launch cannabis legalisation pilot December 2023
News6 months ago
BBC documentary highlights ‘pot luck’ of access to cannabis on NHS
Science5 months ago
New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders
News4 months ago
Europe’s first legal cannabis dispensaries to open under sixth Swiss pilot